BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Job Trends

  Avara Completes Acquisition And Secures Jobs At Avlon Site Near Bristol, UK

  December 5, 2016

   · 

  2 min read
• Drug Development

  Global Blood Therapeutics Announces New Long-Term Clinical Data From Ongoing Phase I/II Trial Of GBT440 In Sickle Cell Disease At American Society of Hematology

  December 5, 2016

   · 

  9 min read
• Drug Development

  AbbVie Release: Favorable Response Rates Suggest Promise Of Ibrutinib (IMBRUVICA) Combination Therapy In Two Common Types Of Non-Hodgkin’s Lymphoma

  December 5, 2016

   · 

  13 min read
• Pharm Country

  11th Double Helix Medals Raises $4.3 Million For Biomedical Research And Education At Cold Spring Harbor Laboratory

  December 5, 2016

   · 

  3 min read
• Drug Development

  uniQure Announces First Clinical Data From Second Dose Cohort Of AMT-060 In Ongoing Phase I/II Trial In Patients With Severe Hemophilia B

  December 5, 2016

   · 

  9 min read
• Week In Review: Suzhou’s Innovent Biologics Announces Record $260 Million Funding

  December 5, 2016

   · 

  1 min read
• Drug Development

  Janssen R&D Release: Data At American Society of Hematology 2016 Show Strong, Lasting Efficacy Of IMBRUVICA (Ibrutinib) Through Five Years Of Treatment For Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

  December 5, 2016

   · 

  12 min read
• Business

  Mission Therapeutics Appoints Colin Goddard As Chairman

  December 5, 2016

   · 

  2 min read
• Austrian Institute of Technology Release: Vine Pest In Austria Is Genetically Variable

  December 5, 2016

   · 

  4 min read
• Drug Development

  Novartis AG Presents Results From First Global Registration Trial Of CTL019 In Pediatric And Young Adult Patients With R/R B-ALL

  December 5, 2016

   · 

  7 min read